Aneuploidy: Cancer's Fatal Flaw?
Author(s)
Williams, Bret R.; Amon, Angelika B
DownloadCancersFatalFlaw.pdf (880.3Kb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Aneuploidy is a characteristic of cancer, with greater than 90% of all solid tumors in humans carrying an aberrant karyotype. Yet, whether or how this condition contributes to tumorigenesis is not understood. Here we summarize our recent findings on the effects of aneuploidy on cell physiology and proliferation. These studies suggest that aneuploidy puts significant stress on the cell, which responds to this condition in what can be viewed as an aneuploidy stress response. We will discuss how our results may bear on our understanding of the role of this condition in tumorigenesis and how they may provide new opportunities for treatment of the disease. [Cancer Res 2009;69(13):5289–91]
Date issued
2009-07Department
Massachusetts Institute of Technology. Department of Biology; Koch Institute for Integrative Cancer Research at MITJournal
Cancer Research
Publisher
American Association for Cancer Research
Citation
Williams, B. R., and A. Amon. “Aneuploidy: Cancer’s Fatal Flaw?” Cancer Research 69.13 (2009): 5289–5291. Web.
Version: Author's final manuscript
ISSN
0008-5472
1538-7445